Tabl of Contents

1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Infoholic Research
3.2 Advantages of Point-of-Care Testing
3.3 Disadvantages of Point-of-Care Testing
3.4 Segmented Addressable Market
3.5 Trends in the Point-of-Care Diagnostics Market
3.6 Related Markets
3.6.1 Molecular Diagnostics
3.6.2 Infectious Disease Diagnostics
4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5 (Five) Forces
5 Market Characteristics
5.1 DRO - Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing prevalence of infectious disease
5.1.1.2 Growing incidence of lifestyle disease
5.1.1.3 Technological innovations
5.1.1.4 Increasing adoption of point-of-care diagnostics
5.1.2 Opportunities
5.1.2.1 Growth opportunities in emerging markets
5.1.2.2 Increasing awareness towards point-of-care diagnostics in developing countries
5.1.3 Restraints
5.1.3.1 Stringent approval process
5.1.3.2 Product recalls
5.1.3.3 Unfavorable reimbursement scenario
5.2 DRO - Impact Analysis
5.3 Key Stakeholders
6 Product: Market Size and Analysis
6.1 Overview
6.2 Glucose Monitoring
6.3 Infectious Disease Testing
6.3.1 Influenza Testing
6.3.2 HIV Testing
6.3.3 Hepatitis Testing
6.3.4 Tuberculosis Testing
6.3.5 Sexually Transmitted Diseases Testing
6.3.6 Healthcare-associated Infections Testing
6.3.7 Respiratory Infections Testing
6.3.8 Others
6.4 Pregnancy and Fertility Testing
6.5 Hematology Testing
6.6 Cardiometabolic Monitoring
6.7 Urinalysis Testing
6.8 Coagulation Monitoring
6.9 Tumor or Cancer Marker Testing
6.10 Cholesterol Testing
6.11 Drugs of Abuse Testing
6.12 Others
7 Prescription Mode: Market Size and Analysis
7.1 Overview
7.2 Prescription-based Point-of-Care Diagnostics
7.3 Over the Counter-based Point-of-Care Diagnostics
8 End-users: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Clinics/Physician Office Laboratory (POL)
8.4 Home Care
8.5 Ambulatory Care
8.6 Others
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 US
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 UK
9.3.3 Germany
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Others
9.4 APAC
9.4.1 Overview
9.4.2 India
9.4.3 China
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
11 Vendors Profile
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Revenue
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Revenue
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Johnson & Johnson
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Danaher Corporation
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Revenue
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Siemens Healthineers Inc. (Siemens AG)
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Revenue
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 Companies to Watch For
12.1 Trinity Biotech plc
12.1.1 Overview
12.2 Qiagen N.V.
12.2.1 Overview
12.3 BioMerieux S.A.
12.3.1 Overview
12.4 OraSure Technologies Inc.
12.4.1 Overview
12.5 Instrumentation Laboratory (A Werfen Company)
12.5.1 Overview
12.6 Becton Dickinson and Company
12.6.1 Overview
12.7 Nova Biomedical
12.7.1 Overview
Annexure
Abbreviations